Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses

por Arodola, Olayide A, Soliman, Mahmoud ES
Publicado 2015

Quantum mechanics implementation in drug-design workflows: does it really help?

por Arodola, Olayide A, Soliman, Mahmoud ES
Publicado 2017

Immunoinformatics prediction of potential B-cell and T-cell epitopes as effective vaccine candidates for eliciting immunogenic responses against Epstein–Barr virus

por Olotu, Fisayo A., Soliman, Mahmoud E.S.
Publicado 2021

Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential ant...

por Cele, Favourite N, Ramesh, Muthusamy, Soliman, Mahmoud ES
Publicado 2016

Using bioinformatics tools for the discovery of Dengue RNA-dependent RNA polymerase inhibitors

por Nncube, Nomagugu B., Ramharack, Pritika, Soliman, Mahmoud E.S.
Publicado 2018

Does Size Really Matter? Probing the Efficacy of Structural Reduction in the Optimization of Bioderived Compounds – A Computational “Proof-of-Concept”

por Olotu, Fisayo A., Munsamy, Geraldene, Soliman, Mahmoud E.S.
Publicado 2018

Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells

por Soremekun, Opeyemi S., Omolabi, Kehinde F., Soliman, Mahmoud E.S.
Publicado 2020

Leaving no stone unturned: Allosteric targeting of SARS-CoV-2 spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor bi...

por Olotu, Fisayo A., Omolabi, Kehinde F., Soliman, Mahmoud E.S.
Publicado 2020

Integrative immunoinformatics paradigm for predicting potential B-cell and T-cell epitopes as viable candidates for subunit vaccine design against COVID-19 virulence

por Sarma, Vyshnavie R., Olotu, Fisayo A., Soliman, Mahmoud E.S.
Publicado 2021

Exploring the effect of ritonavir and TMC-310911 on SARS-CoV-2 and SARS-CoV main proteases: potential from a molecular perspective

por Soremekun, Opeyemi S, Omolabi, Kehinde F, Adewumi, Adeniyi T, Soliman, Mahmoud ES
Publicado 2020

Molecular modelling studies of synthesized pentacyclo-undecane peptides as potential HIV-1 wild type C-SA protease inhibitors

por Honarparvar, Bahareh, Kruger, Hendrik G, Soliman, Mahmoud ES, Maguire, Glenn EM, Govender, Thavendran
Publicado 2013